[Physical Therapy of Non-Exudative Age-Related Macular Degeneration]

Despite the success of anti-VEGF therapy (VEGF: vascular endothelial growth factor) in neovascular age-related macular degeneration (AMD) in the last decade, many unmet needs in AMD management remain. In order to improve patient eye health and relieve the burden on health systems, the development of new intervention options appears to be of great importance if they can delay or even prevent the progression of an early form into a late form. In the field of physical treatment for non-exudative AMD, there is no recognised therapy procedure to date. It now appears appropriate to pursue further research efforts in the field of intraocular blue filter lenses and subthreshold laser treatment in prospective studies. The following article provides an overview of the current strategies of physical therapy for non-exudative AMD.